Alkem Laboratories (ALKEM.NS) Osake Kurssi
Alkem Laboratories Kurssi
Viimeisten 16 vuoden aikana Alkem Laboratoriesn liikevaihto kasvoi 16,1 % vuodessa ja ylsi 147,12 Mrd. INR:een. Osakekohtainen tulos on kasvanut 15,3 % vuodessa viimeisten 16 vuoden aikana. Alkem Laboratoriesn nettomarginaali 15,6 % on pääosin vakaa verrattuna 15,7 %:iin muutama vuosi sitten. Nykyhinnalla osinkotuotto on noin 0,94 %. Jakosuhde on noin 31 % tuloksesta. Osinko on kasvanut 12,5 % vuodessa viimeisten 10 vuoden aikana. Alkem Laboratoriesn 12 kuukauden konsensustavoitehinta on 6 007,80 INR, noin yli kurssia 11,3 %. 27 analyytikosta 15 suosittaa ostoa — kokonaiskonsensus on Osta.
Alkem Laboratories osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Alkem Laboratories liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Alkem Laboratories -osakkeesta
The business model of Alkem Laboratories Ltd revolves around the manufacturing and marketing of pharmaceutical products. As a leading Indian pharmaceutical company, Alkem Laboratories focuses on developing, producing, and distributing a wide range of generic and branded drugs across various therapeutic segments. With a strong emphasis on research and development, Alkem Laboratories aims to consistently bring innovative and affordable healthcare solutions to patients globally. By adhering to stringent quality standards and regulatory requirements, the company strives to maintain its reputation for delivering safe, effective, and high-quality medications. Alkem Laboratories Ltd is committed to improving healthcare accessibility and contributing to a healthier society.
Alkem Laboratories Ltd is primarily active in the pharmaceutical industry.
The main competitors of Alkem Laboratories Ltd in the market are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr. Reddy's Laboratories Ltd, Lupin Ltd, and Torrent Pharmaceuticals Ltd.
Alkem Laboratories Ltd. is a renowned pharmaceutical company with a rich history and background. Established in 1973, Alkem has consistently shown remarkable growth and has become one of India's leading pharmaceutical enterprises. The company is primarily engaged in the development, manufacturing, and marketing of a diverse range of pharmaceutical products for both domestic and international markets. Alkem Laboratories Ltd. has earned a stellar reputation for its high-quality products, state-of-the-art manufacturing facilities, and extensive research and development capabilities. With a strong focus on innovation and compliance with global quality standards, Alkem Laboratories Ltd. continues to make a significant impact in the healthcare industry, contributing to the overall wellness and patient care.
Alkem Laboratories Ltd has achieved several significant milestones throughout its journey. The company expanded its operations globally by establishing subsidiaries and offices in multiple countries. It received various certifications and accreditations, including the US FDA approvals for several of its manufacturing facilities. Alkem Laboratories Ltd has consistently focused on research and development, leading to the successful launch of innovative and affordable pharmaceutical products. Additionally, the company has fostered strong partnerships with renowned global pharmaceutical companies, enabling it to expand its product portfolio. Alkem Laboratories Ltd continues to demonstrate its commitment to excellence and is regarded as a leading player in the pharmaceutical industry.
Alkem Laboratories Ltd is primarily present in multiple countries and regions worldwide. Some of the key areas where Alkem operates include India, the United States, Europe, Latin America, and various Asian and African countries. With a strong global presence, Alkem Laboratories has established a robust network and continually expands its reach to cater to diverse markets.
Alkem Laboratories Ltd represents values of integrity, quality, and innovation. The company prioritizes ethical business practices and strives for excellence in product manufacturing and distribution. Alkem Laboratories believes in delivering high-quality healthcare solutions to improve patients' lives. The company's corporate philosophy revolves around continuously investing in research and development, fostering a culture of learning and growth, and maintaining strong relationships with healthcare professionals and stakeholders. By upholding these values, Alkem Laboratories positions itself as a trusted and reliable pharmaceutical company in the market.
Analyytikot asettavat tällä hetkellä Alkem Laboratories-osakkeelle keskimääräisen tavoitehinnan 5 966,79 INR (mediaani: 6 007,80 INR), mikä merkitsee +10,5 % viimeisimpään hintaan verrattuna. Konsensus perustuu 27 analyytikkoarvioon.
27 analyytikkoa arvioi tällä hetkellä Alkem Laboratories-osaketta: 15 suosittaa ostoa, 9 pitoa ja 3 myyntiä.
Nykyisellä valuuttakurssilla Alkem Laboratories-osake noteerataan hintaan 51,32 EUR (5 398,50 INR).
Alkem Laboratories-osake (ALKEM.NS) on listattuna 2 pörssissä, muun muassa: NSE (Indien) (ALKEM.NS).
Alkem Laboratories Ltd is a leading pharmaceutical company based in India and operates globally. The company is involved in various divisions, including generics, branded generics, OTC products, APIs, and biosimilars. The generics division of Alkem Laboratories Ltd is one of the largest in India, covering a wide range of therapeutic areas. The company also produces a variety of branded generics under the name "Alkem's Brand," including dermatology, gastroenterology, cardiology, neurology, and gynecology products. Alkem Laboratories Ltd also offers a range of OTC products, including antacids, pain relievers, cough and cold products, vitamins, and minerals. They have a strong presence in this market segment and their products are available in India and other countries. Additionally, the company is involved in API production, which serve as key intermediates for drug manufacturing. They have a wide range of APIs used in various therapeutic areas. Alkem Laboratories Ltd is also involved in the development of biosimilars, with a strong pipeline in various stages of development, covering areas such as oncology, autoimmune diseases, and diabetes. The company has a strong presence in India and operates globally, with a focus on providing high-quality and affordable medicines that meet customer needs. They invest in research and development to continually develop new products and have a strong distribution infrastructure to quickly bring products to market and strengthen their presence. Overall, Alkem Laboratories Ltd aims to offer a wide range of products and divisions to meet market demand, with a strong team and modern infrastructure positioning them to expand their market presence in India and globally. The business model of Alkem Laboratories Ltd is focused on providing high-quality and affordable medicines that meet customer needs.
liikevaihto Alkem Laboratories on 147,12 Mrd. INR. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
voitto Alkem Laboratories on 23,02 Mrd. INR. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Alkem Laboratories:n hinta-voitto-suhde (P/E) on tällä hetkellä 28,04. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Alkem Laboratories-osakkeen arvostusta.
Alkem Laboratories:n hinta-myynti-suhde (P/S) on tällä hetkellä 4,39. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Alkem Laboratories-osakkeen arvostuskennuslukuna.
Alkem Laboratories:n Eulpool-laatuscore on 10/10.
Alkem Laboratories:n ISIN on INE540L01014. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Alkem Laboratories:n ticker on ALKEM.NS. Tämä pörssinoteeraus käytetään Alkem Laboratories-osakkeiden kauppaan pörssissä.
Alkem Laboratories osake
Alkem Laboratories vertaisryhmä
Alkem Laboratories Ticker
Alkem Laboratories FIGI
Kaikki tunnusluvut ja syvällinen analyysi Alkem Laboratories:sta
Meidän osakeanalyysimme Alkem Laboratories-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Alkem Laboratories:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: